Oral Medications for Multiple Sclerosis
Oral Medications for Multiple Sclerosis Market by Molecule (Dimethyl Fumarate, Diroximel Fumarate, Fingolimod), Drug Class (Dihydroorotate Dehydrogenase Inhibitors, Fumarates, Sphingosine 1 Phosphate Receptor Modulators), Indication, Line Of Therapy, Dosage Form, Distribution Channel - Global Forecast 2026-2032
SKU
MRR-7A380DA7C450
Region
Global
Publication Date
June 2026
Delivery
Immediate
2025
USD 6.37 billion
2026
USD 6.76 billion
2032
USD 10.44 billion
CAGR
7.31%
PURCHASE OPTIONS
1-5 Users License PDF, Excel, and Online Access
$3,939
Enterprise License PDF, Excel, and Online Access
$5,959

Oral Medications for Multiple Sclerosis Market - Global Forecast 2026-2032